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Diabetes mellitus has many forms. Neonatal
diabetes mellitus is one of the rarest, with a
reported incidence of 1 in 450,000 live births.1 2
ThefirstcasewasdescribedbyKitselle (1852)in
hisownnewborn son, who subsequently died.3 In
Northern Ireland, one case might be expected
approximatelyevery 16years;thelastdocumented
herewasbornin 1983.4Severalliteraturereviews
havehighlightedthecharacteristicclinicalpicture
ofthis disease.
Neonataldiabetesmellitusisdefinedaspersistent
hyperglycaemia withinthe first six weeks oflife,
requiringinsulinfortwoormoreweeks,ininfants
of 37 or more weeks gestation.2'5 Alternative
names are temporary idiopathic neonatal
hyperglycaemia, neonatal pseudodiabetes
mellitus, transient diabetes of early infancy and
congenital temporary diabetes mellitus.5,6
Neonataldiabetesdiffersfrominsulin-dependent
(type I) diabetes in that it has a highly variable
course. Some patients have permanent diabetes,
while others have transient orlastingremissions.
We report the latest case from Belfast.
CASEREPORT A male infant was admitted to
the Royal Belfast Hospital for Sick Children in
April 1998, agedsixweeks. Hewasthefirstchild
of unrelated parents. His mother suffered from
systemic lupus erythematosus and was treated
with prednisolone 10 mg daily throughout the
pregnancy. She had an uneventful antenatal
course,buthadproteinuriaandmildhypertension
atterm. Shehad anormal delivery at 37 weeks of
a male infant weighing 2.27 kg (2nd centile). He
was well at birth and on account ofthe maternal
history of systemic lupus erythematosus and
increased risk of congenital heart block, he had
an electrocardiograph before discharge, which
was normal.
He fed eagerly and always appeared hungry. His
parents contacted the health visitor as he was
drinking excessive quantities of formula milk
(3 oz every two hours, equivalent to 265 mls/kg/
day). He had no vomiting or diarrhoea, but was
notgaining weight. Twodayspriorto admission,
he became very irritable and had some loose
motions. His colour became grey and mottled.
Onadmissionhewasprofoundlydehydratedwith
adepressedfontanelle; his eyes were alertbuthe
was very agitated. He was extremelyrestless and
appearedemaciated, withtachycardia(200/min),
tachypnoea (65/min) and fever of 38°C. He
showedanunusuallyhighlevel ofconsciousness
for such a severely dehydrated infant. A ketotic
smell was evident. He passed large volumes of
dilute urine; urinalysis showed glucose ++++,
protein++,blood+andstronglypositiveketones.
Blood gas analysis showed marked metabolic
acidosis (pH 7.162, P02 15.0 kPa, pCO2 1.41
kPa, HCO3 3.7 mmol/l and Base excess - 22.7
mmol/i).Biochemicalparameterswereinkeeping
with the clinical signs ofdehydration and severe
hyperglycaemia (serum glucose 73.2 mmol/l, Na
154 mmol/l, K 5.8 mmol/l, Urea 15.1 mmol/l,
Creatinine 62umol/l, Hb 10.7 g/dL,WCC 19.4x
103/ug, platelets 737 x 103/ug).
Initial management was with plasma volume
expansion with human plasma protein fraction
andsaline,totalvolume40ml/kg,andintravenous
insulininfusion.Duringrehydrationhedeveloped
poor peripheral perfusion with oxygen
desaturation, opisthotonus and seizure activity.
He was transferred to the paediatric intensive
careunitandwassedated,mechanicallyventilated
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for three days and treated with anticonvulsants.
Hisbloodglucoselevelsfellslowlywithrepeated
insulin injections. He resumed oral feeds and
remained aninpatientfor24 days to establish the
insulin and feeding pattern. By the age of 10
weekshisweighthadincreasedtothe25thcentile
(5.16 kg).
A 14 months his developmental milestones were
all normal. He remained on twice-daily
subcutaneousmedium-actinginsulin.Homeblood
sugars were monitored daily and he had no
apparent episodes of hypoglycaemia. HbA1c
concentration was 7.1% at age 16 months. To
date there has been no evidence ofremission and
it is probable that diabetes will be a long-term
problem.
DISCUSSION
Only 0.5% ofchildren with diabetes develop the
diseaseduringthefirstyearoflife.5Theincidence
of newly diagnosed type I diabetes mellitus in
Northern Ireland is 19.6 per 100,000 children
under 15 years, and 18% of cases are under five
years atdiagnosis.7Longtermstudiesofneonatal
diabetes world-wide have shown that
approximately42%havepermanentdiabetes and
58% have aperiod ofremission, with 65% ofthe
transient forms subsequently becoming diabetic
again. Infants with the transient form usually
become euglycaemic without insulin treatment
within the first year.8
Babies with neonatal diabetes are usually small
for dates term infants, as found in the case
presented. In one study, 41 out of 45 babies
(91%) hadlowbirthweight(<2ndcentile).2They
develophyperglycaemiawithseveredehydration
and minimal ketosis. Seventy-five percent of
cases firstpresentwith symptoms within 10 days
ofbirth.5 Thepicture ofalively, alertbutgrossly
dehydrated child is classical, in contrast to the
semicomatose state and glazed-eye appearance
usual in severely dehydrated infants.3'6 Polyuria
is difficult to recognise in the newborn.
With few exceptions, most infants require
exogenous insulin. Total daily doses of 0.2-1.0
units/kg are usually sufficient to establish
normoglycaemia,andmildhyperglycaemicvalues
are well tolerated. Hypoglycaemia is the greatest
complication ofinsulin therapy, with associated
risk of cerebral damage.3'6'9 Small, intermittent
doses of regular insulin, along with frequent
blood sugarmonitoringhasbeenadvisedto avoid
hypoglycaemia.'0 After initiation of insulin
therapy, weight gain usually accelerates.3'5
Thefrequencyofrelapseinchildrenwithtransient
neonataldiabetes isdifficulttodefine. Onestudy
showed a median duration of exogenous insulin
requirementofthreemonths,1 andanothershowed
a mean insulin requirement of 120 days;2 and a
period of remission until later recurrence of
diabetes of7-20 years (median 13 years).2 Long
term follow-up of the later onset diabetes is not
the classical autoimmune related type I form of
childhood, but is consistent with type II diabetes
with insulin resistance.1'8
Varioussuggestions astothepathogenesis ofthis
conditionhavebeenproposed, includingreduced
insulinproductionfrompancreaticdysmaturity,'1
insulin resistance8' 9 and insulinopenia from a
poor response of the pancreatic beta cell to
hyperglycaemia.5 The onset ofislet cell damage
ordestruction is thought to start in utero, as poor
insulin secretion by the pancreas has been
quantified by low levels of C-peptide in the
neonatal period.4'12 The fact that mostbabies are
low birthweight may berelated to the lackofthe
anabolic effect ofinsulin, as insulin is one ofthe
maingrowthfactorsin-utero.1 12Theautoimmune
theory of classical juvenile type I insulin
dependent diabetes is not applicable to neonatal
diabetes, as there has been no evidence of islet
cell antibodiesdeveloping." 2,5Heredityplays an
importantrole as approximately 25% ofneonatal
caseshave anaffectedsibling (withtypeIinsulin
dependent diabetes), with equal sex ratios.5'6
Minorities of patients have shown HLA
haplotypestypicalforinsulin-dependentdiabetes
(HLA DR3 and DR4).2
Recently, the genetic basis of neonatal diabetes
hasbeenstudied. Shieldetalshowedonmolecular
DNA analysis paternal uniparental disomy of
chromosome 6 inmany cases withthetemporary
formofneonatal diabetes. 11" 13This refers tothe
inheritance of both chromosomes of one pair
from one parent only, with no contribution from
the other. The findings predict that neonatal
diabetes is due to the overexpression of an
imprinted gene at 6q22-23,'13'14 and this gene
may prove to be an important factor in the
aetiology of more common types of adult
diabetes.'4 Hermann et al suggested that the two
phenotypes oftransient and permanent neonatal
diabetes have different genetic backgrounds, as
noneofthecaseswithpermanentneonataldiabetes
C The Ulster Medical Society, 2000.Neonatal diabetes mellitus 73
have shown the paternal uniparental disomy of
chromosome 6.15
Several associations of neonatal diabetes with
other developmental or dysmorphic syndromes
havebeendescribed.Tencaseshavebeenreported
of the Wolcott-Rallinson syndrome (a rare
autosomal recessive condition characterised by
diabetes mellitus in early infancy and multiple
epiphyseal dysplasia) all of whom have had
permanent diabetes, and a high risk of early
mortality from renal impairment.2'16 Two cases
have been described of brothers with X-linked
hyperuricaemia, secondary to phosphoribosyl-
ATPpyrophosphatasehyperactivitywhobecame
diabetic within the first day of life, both had
severe developmental delay.2 Macroglossia has
been reported in patients with transient neonatal
diabetes, this feature becomes less pronounced
with age." 15
Thecombinationofsystemiclupuserythematosus
and pregnancy increases both fetal and maternal
risks,withareported20-60%flareupofsystemic
lupus erythematosus, 23% early foetal loss, 50%
pre-term delivery and 10% growth retardation.'7
The infants have an increased risk ofcongenital
heartblock,neonatallupusandintra-uterinedeath.
Systemicprednisolone 10mg/dayiswelltolerated
in planned systemic lupus erythematosus
pregnancies.'7 We have found no previous
reported cases of maternal systemic lupus
erythematosus and neonatal diabetes mellitus,
although one infant with initial hypoglycaemia,
who was treated with steroids and subsequently
developedhyperglycaemiarequiringinsulin, has
been classified as "steroid-provoked" diabetes.9
Theoveralloutcomeforgeneralhealthandnormal
intellectual development is usually good
Complications ofvasculopathy are rare in long-
term follow up-reports over 20 years.2'5 The
prognosis is worst in permanent diabetes with
onset after one month of age, and in association
with HLA DR3/DR4 halotypes, and the other
rarer associated syndromes.2
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